NCT03723954

Brief Summary

Ryder Heart is an exploratory study of the heart rate variations of golf fans during the 2018 edition of the Ryder Cup. The main objective is to evaluate the impact of stress and strong emotions on heart rate variations and the occurrence of rhythmic anomalies in golf fans during this high-level golf competition. Such data are actually poorly described in medical and scientific literature.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
47

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 27, 2018

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2018

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

October 22, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 30, 2018

Completed
Last Updated

October 30, 2018

Status Verified

October 1, 2018

Enrollment Period

3 days

First QC Date

October 22, 2018

Last Update Submit

October 26, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Record and measure by Spider Flash-t of the increase in the heart rate peak

    The measure of the increase in the heart rate peak (in beats per minute) of study subjects at the days and times of golf matches will be performed with Spider Flash-t. The algorithms built into SpiderFlash-t detect episodes palpitations, syncope, atrial fibrillation and atrial flutter in addition to all other arrhythmias such as bradycardia and tachycardia in patients symptomatic and asymptomatic. The integrated SpiderFlash-t software includes a dedicated and specific algorithm for detect atrial fibrillation. This atrial fibrillation algorithm is independent of the algorithm main arrhythmia detection, also incorporated into SpiderFlash-t. So comparing the data recorded at V0 (baseline) with the data recorded during the golf match, a minimum increase in the heart rate peak of at least 10% (at days and times of golf meetings) will be considered a significant variation.

    3 days

Secondary Outcomes (3)

  • average hourly variations of parameters related with heart rate

    3 days

  • Fan's passion score for golf

    15 minutes

  • Record and measure fan physical activity by ActiGraph GT3Xp

    3 days

Interventions

Record at visit V0 (day without match) and the competition days (Visit V1, V2 et V3) during the matches the heart rate of the golf fans. SpiderFlash-tâ„¢ from MicroPort is a long-lasting event recorder set in walking position by the investigator the day of the record and it is activated by detecting rhythm anomalies. This recorder is a Class IIA medical device (according to European Economic Community Directive 93/42). It benefits from European Economic marking.

Record the study participant's physical activity while we record his heart rate. The GT3Xp based activity monitors provide objective measurements of human activity and are used in many research and clinical applications. It includes a micro-electro-mechanical system (MEMS) based accelerometer and an ambient light sensor. It benefits from CE marking and FDA agreement (Class II medical device).

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Golf fans attending at least one Ryder Cup match

You may qualify if:

  • Man or a Woman golf fan ;
  • At least 18 years old ;
  • Either a healthy study volunteer or a study volunteer suffering from a heart disease ;
  • With or without an implantable cardioverter-defibrillator ;
  • Presence at the Golf National during at least one day of the Ryder Cup (September 28th and/or September 29th and/or September 30th, 2018);
  • In the Ile de France zone on the eve of competition (September 27th, 2018);
  • At Golf National at least two hours before matches' beginning at competition days ;
  • In possession of official tickets issued by the organizers ;

You may not qualify if:

  • Pregnant or lactating woman;
  • Medical contraindication to ECG Holter ;
  • Equipped with an implantable pacemaker ;
  • Total dependence to stimulation of cardiac defibrillator;
  • Suffering from a decompensated heart disease ;
  • History of severe allergy to angioedema-type electrodes ;
  • Not opposed to the use of data collected via recording and electromagnetic measurements of heart rate (ECG) for research purposes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Golf National

Saint-Quentin-en-Yvelines, 78280, France

Location

Related Publications (2)

  • Spitters CE. Cardiovascular events during World Cup soccer. N Engl J Med. 2008 May 29;358(22):2408; author reply 2409. No abstract available.

  • Vallerand RJ, Ntoumanis N, Philippe FL, Lavigne GL, Carbonneau N, Bonneville A, Lagace-Labonte C, Maliha G. On passion and sports fans: a look at football. J Sports Sci. 2008 Oct;26(12):1279-93. doi: 10.1080/02640410802123185.

Study Officials

  • Fabrice DEMONIERE, MD

    CHU deMartinique

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 22, 2018

First Posted

October 30, 2018

Study Start

September 27, 2018

Primary Completion

September 30, 2018

Study Completion

September 30, 2018

Last Updated

October 30, 2018

Record last verified: 2018-10

Data Sharing

IPD Sharing
Will share

All collected IPD, all IPD that underlie results in a publication.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
After the main publication of the results, for not limited time.
Access Criteria
The conditions for the transfer of all or part of the database of the research are decided by the principal investigator / sponsor of the research and are the subject of a written contract.

Locations